WMT targets the proteotoxic stress response / UPR to shut down cancer cell metabolism. This limits tumor autonomous growth and lowers intratumoral lactate to stimulate the immune system to re-attack the tumor.
Our TOBY program is a combination of targeted chemotherapy with an immunooncology approach, casted into a single small molecule.
Industry
Biotechnology Research, Scientific Research and Development Services, Services
HQ Location
Waldhofer Str. 104
Heidelberg, Germany 69123, DE
Keywords
immune cellkiller cellsmaterial and buildinglipid synthesisimmune surveillancetherapeutic dosingmouse cursorbrowser securitymolecule lactate inhibitormouse cancer